Related Experiment Video
Updated: Aug 1, 2026

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
Association of left bundle branch block with left ventricular structure and function in hypertensive patients with
1Department of Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA.
Insights
Electrocardiographic left bundle branch block (LBBB) in hypertensive patients with left ventricular hypertrophy (LVH) indicates worse cardiac function, even without increased LVH severity. This finding highlights LBBB as a marker for impaired systolic and diastolic function.
Area of Science:
- Cardiology
- Hypertension Research
- Cardiac Electrophysiology
Background:
- Electrocardiographic (ECG) left bundle branch block (LBBB) is linked to left ventricular hypertrophy (LVH).
- The relationship between LBBB and left ventricular (LV) geometry/function in hypertensive patients with ECG LVH remains unclear.
Purpose of the Study:
- To investigate the association between LBBB and LV geometry and function.
- To determine if LBBB identifies hypertensive patients with LVH who have poorer cardiac performance.
Main Methods:
- Echocardiograms were analyzed in 933 hypertensive patients with ECG LVH from the LIFE study.
- Patients were categorized based on the presence (n=47) or absence (n=886) of LBBB.
- Multivariate analyses adjusted for clinical and echocardiographic parameters.
Main Results:
- Patients with LBBB showed significantly lower LV fractional shortening, ejection fraction, midwall shortening, and stroke index.
- Reduced LV inferior wall motion and impaired LV relaxation (lower mitral E/A ratio) were observed in LBBB patients.
- These functional deficits were present despite similar LV mass and relative wall thickness between groups.
Conclusions:
- In hypertensive patients with ECG LVH, LBBB identifies individuals with worse global and regional LV systolic function.
- LBBB is associated with impaired LV relaxation, independent of LVH severity.
- LBBB serves as a marker for poorer cardiac function in this high-risk population.
Abstract:
Electrocardiographic (ECG) left bundle branch block (LBBB) is associated with left ventricular hypertrophy (LVH), but its relation to left ventricular (LV) geometry and function in hypertensive patients with ECG LVH is unknown. Echocardiograms were performed in 933 patients (548 women, mean age 66+/-7 years) with essential hypertension and LVH by baseline ECG in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study. LBBB, defined by Minnesota code 7.1, was present in 47 patients and absent in 886 patients. Patients with and without LBBB were similar in age, gender, body mass index, blood pressure, prevalence of diabetes, and history of myocardial infarction. Despite similarly elevated mean LV mass (126+/-25 vs 124+/-26 g/m(2)) and relative wall thickness (0.41+/-0.07 vs 0.41+/-0.07, P=NS), patients with LBBB had lower LV fractional shortening (30+/-6 vs 34+/-6%), ejection fraction (56+/-10 vs 61+/-8%), midwall shortening (14+/-2 vs 16+/-2%), stress-corrected midwall shortening (90+/-13 vs 97+/-13%) (all P<0.001), and lower LV stroke index (38+/-7 vs 42+/-9 ml/m(2)) (P<0.05). Patients with LBBB also had reduced LV inferior wall and lower mitral E/A ratio (0.75+/-0.18 vs 0.87+/-0.38) (all P<0.05). The above univariate results were confirmed by multivariate analyses adjusted for gender, age, blood pressures, height, weight, body mass index, heart rate, and LV mass index. Among hypertensive patients at high risk because of ECG LVH, the presence of LBBB identifies individuals with worse global and regional LV systolic function and impaired LV relaxation without more severe LVH by echocardiography.
Related Concept Videos
Mitral Regurgitation I: Introduction
Mitral Stenosis I: Introduction
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Heart Failure II: Pathophysiology
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertension III: Clinical Manifestations and Diagnostic Studies

